Table 1.
Organ | Severity stage | Modified Glucksberg (Keystone aGvHD consensus) criteria and IBMTR criteria (66, 67) | MAGIC criteria (68) |
---|---|---|---|
Skin | 0 | No rash | |
1 | Rash <25% BSA | ||
2 | Rash 25–50% BSA | ||
3 | Rash >50% BSA | ||
4 | Generalised erythroderma with bullous formation | Generalised erythroderma (>50% BSA) plus bullous formation and desquamation >5% BSA | |
Liver | 0 | Total serum bilirubin <2 mg/dL | |
1 | Total serum bilirubin 2–3 mg/dL | ||
2 | Total serum bilirubin 3.1–6 mg/dL | ||
3 | Total serum bilirubin 6.1–15 mg/dL | ||
4 | Total serum bilirubin >15 mg/dL | ||
Upper GI tract | 0 | No persistent nausea and no histologic evidence of GvHD in the stomach or duodenum | No or intermittent anorexia or nausea or vomiting* |
1 | Persistent nausea with histologic evidence of GvHD in the stomach or duodenum | Persistent anorexia or nausea or vomiting* | |
Lower GI tract | 0 | Diarrhoea ≤ 500 mL/day | Diarrhoea <10 mL/kg/day or <4 episodes/day† |
1 | Diarrhoea >500 mL/day | Diarrhoea 10–19.9 mL/kg or 4–6 episodes/day† | |
2 | Diarrhoea >1,000 mL/day | Diarrhoea 20–30 mL/kg/day or 7–10 episodes/day† | |
3 | Diarrhoea >1,500 mL/day | Diarrhoea >30 mL/kg/day or >10 episodes/day† | |
4 | Severe abdominal pain with or without ileus | Severe abdominal pain with or without ileus or grossly bloody stools (regardless of stool volume) |
Adapted with permission from Schoemans et al. (70).
Anorexia accompanied by weight loss, nausea lasting ≥3 days or accompanied by ≥2 vomiting episodes per day for ≥2 days.
One episode of diarrhoea in children weighing <50 kg is considered equivalent to 3 mL/kg. aGvHD, acute graft versus host disease; BSA, body surface area; GI, gastrointestinal; IBMTR, International blood and marrow transplant registry; MAGIC, Mount sinai acute GvHD international consortium.